VitaDX completes a €3M financing round with its historical investors GO CAPITAL, ODYSSEE Venture and FFBB Management and its financial partners…
VitaDX is very proud to announce the CE marking of its first software solution dedicated to bladder cancer diagnosis: VisioCyt®.
This fundraising will allow VitaDX to finalize the development and ensure the commercial deployment of its first early bladder cancer detection…
Allan Rodriguez (CEO and co-founder of VitaDX) and Pascal Eschwège (Professor of Urology at the University Hospital of Nancy and co-founder of…
VitaDX is very happy to be a Health & Wellness Laureate at DeepTech4Good !
VitaDX is very pleased to be part of the 5 Therapeutic Innovation Startups selected by AstraZeneca to be part of the support program REALIZE!
VitaDX citée dans Le Mag numérique à l'occasion de la journée Numérique & Santé.
Interview of Allan Rodriguez, innovation guest in the France Culture Soft Power radio program.
VitaDX among the 20 best rated french startups.
